Position in LLY
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$226,073,382
+$52,815,389 QoQ
Shares Held
188,484
+0.1% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
4.32%
of 13F equity value
Holder Rank
#248
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Glenview Trust Co holds $465,808,551 across 12 Drug Manufacturers - General names. LLY ranks #1 (48.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
188,484 | $226,073,382 | |
| 2 | ABBV |
AbbVie Inc.
|
422,207 | $106,244,168 | |
| 3 | MRK |
Merck & Co., Inc.
|
381,609 | $49,036,756 | |
| 4 | JNJ |
Johnson & Johnson
|
150,964 | $38,340,326 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
195,795 | $24,736,739 | |
| 6 | PFE |
Pfizer Inc
|
442,787 | $10,662,310 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
102,223 | $5,890,089 | |
| 8 | AMGN |
Amgen Inc
|
8,321 | $3,013,200 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $226,073,382 | 188,484 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $173,257,993 | 188,371 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $203,994,701 | 189,819 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $145,589,556 | 190,812 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $148,325,849 | 190,276 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $156,188,665 | 189,111 | Shares | Sole | 2025-05-20 | |
| 2024-12-31 | $147,043,612 | 190,471 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $168,370,238 | 190,047 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $174,834,310 | 193,106 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $153,708,558 | 197,579 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $114,531,537 | 196,479 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $106,096,602 | 197,525 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $99,050,451 | 211,204 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $80,024,757 | 233,023 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $50,557,989 | 138,197 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $45,449,428 | 140,558 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $46,280,914 | 142,741 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $43,267,356 | 151,089 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $40,542,189 | 146,775 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $33,076,886 | 143,159 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $32,144,504 | 140,051 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $22,429,609 | 120,060 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $12,227,730 | 72,422 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $10,774,967 | 72,794 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $12,220,245 | 74,432 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $10,757,319 | 77,547 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||